Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain pacemaker study aims to shake up essential tremor treatment

NCT ID NCT04032470

Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 5 times

Summary

This study is collecting information from 500 people with essential tremor who are using a Boston Scientific deep brain stimulation (DBS) system, which is already approved for use. The goal is to see how the device affects quality of life in real-world settings, not just in controlled experiments. Participants will fill out questionnaires over time to track changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2019

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects with Essential Tremor

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Meets criteria established in the locally applicable Directions for Use (DFU) for Essential Tremor * Is at least 18 years old Exclusion Criteria: * Meets any contraindication in locally applicable Directions for Use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Essential tremor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

essential tremor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Essential tremor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    18 sites in 8 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • A.o. LKH Univ.-Kliniken Innsbruck

    RECRUITING

    Innsbruck, Austria

  • AZ Delta

    RECRUITING

    Roeselare, Belgium

  • AZ Sint-Lucas

    RECRUITING

    Ghent, Belgium

  • CHU Sao Joao

    RECRUITING

    Porto, Portugal

  • Evangelisches Krankenhaus Oldenburg

    RECRUITING

    Oldenburg, Germany

  • Hospital De Bellvitge

    RECRUITING

    Barcelona, 30326, Spain

  • Hospital General De Asturias

    RECRUITING

    Oviedo, Spain

  • Medical School of University PECS

    RECRUITING

    Pécs, Hungary

  • Policlinico Universitario Agostino Gemelli

    WITHDRAWN

    Rome, Italy

  • Samsung Medical Center

    RECRUITING

    Seoul, South Korea

  • Seoul ASAN Medical Center

    WITHDRAWN

    Seoul, South Korea

  • UZ Gasthuisberg

    RECRUITING

    Leuven, Belgium

  • Uniklinik Koln

    RECRUITING

    Cologne, Germany

  • Universitaetsklinikum Dusseldorf

    RECRUITING

    Düsseldorf, Germany

  • Universitaetsklinikum Essen

    RECRUITING

    Essen, Germany

  • Universitaetsklinikum Giessen und Marburg GmbH

    RECRUITING

    Marburg, Germany

  • Universitaetsklinikum Wuerzburg

    RECRUITING

    Würzburg, Germany

  • Universitatsklinikum Campus Kiel

    RECRUITING

    Kiel, Germany

  • Vancouver General Hospital

    RECRUITING

    Vancouver, Canada

  • Yonsei University Severance Hospital

    RECRUITING

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.